← Eichor
Study identifier: NCT07113522 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

Condition: Inflammatory Bowel Disease (IBD) · Ulcerative Colitis (UC) · Crohn's Disease  ·  Sponsor: Mirador Therapeutics, Inc.

PhasePhase 2
Planned participants140
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersNo

About this study

This is a Phase 2, multicenter, platform study in adult participants with IBD (moderately to severely active Crohn's Disease or Ulcerative Colitis). The primary goal of this study is to assess the safety and efficacy of multiple investigational drugs.

This description comes directly from the study's public registry record.

Talk to the study team

ASCEND-IBD Trial Center  ·  844-206-4980  ·  clinicaltrials@miradortx.com

Always discuss trial participation with your own doctor first.

Locations (66)

Mirador Therapeutics Selected SiteBirmingham, Alabama, United StatesRecruiting
Mirador Therapeutics Selected SiteScottsdale, Arizona, United StatesRecruiting
Mirador Therapeutics Selected SiteSun City, Arizona, United StatesRecruiting
Mirador Therapeutics Selected SiteLittle Rock, Arkansas, United StatesRecruiting
Mirador Therapeutics Selected SiteLittle Rock, Arkansas, United StatesRecruiting
Mirador Therapeutics Selected SiteColorado Springs, Colorado, United StatesRecruiting
Mirador Therapeutics Selected SiteLittleton, Colorado, United StatesRecruiting
Mirador Therapeutics Selected SiteMiami, Florida, United StatesRecruiting
Mirador Therapeutics Selected SiteMiami, Florida, United StatesRecruiting
Mirador Therapeutics Selected SiteMiami, Florida, United StatesRecruiting
Mirador Therapeutics Selected SiteOrlando, Florida, United StatesRecruiting
Mirador Therapeutics Selected SitePalmetto Bay, Florida, United StatesRecruiting

+ 54 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07113522